Capping off a dire run of bad news in the last year, 23andMe announced last week that it will be acquired, in a new twist, by a nonprofit called TTAM Research Institute led by 23andMe co-founder Anne ...

Genetic testing company 23andMe never hit on a sustainable business model and went bankrupt. Now, it's being sold to a non-profit launched by the co-founder, delaying addressing data privacy concerns.

A bankruptcy judge has approved the sale of the insolvent genetics firm 23andMe to a nonprofit run by one of the company's co-founders. The deal effectively avoids the controversial transfer of DNA ...

23andMe’s sale to Regeneron is not yet a done deal. The privacy ombudsman is scheduled to report on the privacy aspects of the sale by mid-June.

Dozens of states have filed a joint lawsuit against the bankrupt DNA-testing company 23andMe to block the company’s sale of its customers’ genetic data without explicit consent. The suit, filed this ...

23andMe was once a high-flying biotech firm. It collected a trove of DNA data on millions of its customers, and then it went bust. The fate of that data has been at the center of a legal battle over ...

The prospect of 23andMe’s trove of genetic information on millions of people passing to the highest bidder had sparked outcry when it was announced in May that New York-based Regeneron Pharmaceuticals ...